Regulus Therapeutics Inc. (RGLS) Debt-to-equity % [USD] 2013 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Regulus Therapeutics Inc. quarterly Debt-to-equity history and growth rate from 2013 to 2024.
  • Regulus Therapeutics Inc. Debt-to-equity for the quarter ending March 31, 2024 was 18.5 %, a 45.7% decline year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 18.5 -15.5 -45.7% Mar 31, 2024
Q4 2023 35.6 +5.44 +18.1% Dec 31, 2023
Q3 2023 35.2 +8.54 +32% Sep 30, 2023
Q2 2023 34.4 +5.25 +18% Jun 30, 2023
Q1 2023 34 +3.43 +11.2% Mar 31, 2023
Q4 2022 30.1 -5.68 -15.9% Dec 31, 2022
Q3 2022 26.7 -16.2 -37.9% Sep 30, 2022
Q2 2022 29.2 -28.7 -49.6% Jun 30, 2022
Q1 2022 30.6 -63.1 -67.4% Mar 31, 2022
Q4 2021 35.8 -90.8 -71.7% Dec 31, 2021
Q3 2021 42.9 -119 -73.5% Sep 30, 2021
Q2 2021 57.9 -138 -70.4% Jun 30, 2021
Q1 2021 93.7 -121 -56.3% Mar 31, 2021
Q4 2020 127 -362 -74.1% Dec 31, 2020
Q3 2020 162 +1.56 K Sep 30, 2020
Q2 2020 196 +2.23 K Jun 30, 2020
Q1 2020 214 -149 K -99.9% Mar 31, 2020
Q4 2019 488 -11.1 -2.22% Dec 31, 2019
Q3 2019 -1.4 K -1.62 K -737% Sep 30, 2019
Q2 2019 -2.03 K -2.17 K -1562% Jun 30, 2019
Q1 2019 150 K +149 K +114111% Mar 31, 2019
Q4 2018 499 +381 +323% Dec 31, 2018
Q3 2018 219 +115 +111% Sep 30, 2018
Q2 2018 139 +47.6 +52% Jun 30, 2018
Q1 2018 131 +64.1 +95.9% Mar 31, 2018
Q4 2017 118 +71.6 +154% Dec 31, 2017
Q3 2017 104 +72.8 +232% Sep 30, 2017
Q2 2017 91.5 +69.7 +320% Jun 30, 2017
Q1 2017 66.9 +51.9 +348% Mar 31, 2017
Q4 2016 46.4 +33.1 +250% Dec 31, 2016
Q3 2016 31.3 +14.1 +81.6% Sep 30, 2016
Q2 2016 21.8 +0.13 +0.6% Jun 30, 2016
Q1 2016 14.9 -12.5 -45.5% Mar 31, 2016
Q4 2015 13.3 -21.7 -62% Dec 31, 2015
Q3 2015 17.3 -18.8 -52.1% Sep 30, 2015
Q2 2015 21.6 -14.1 -39.4% Jun 30, 2015
Q1 2015 27.4 -15.3 -35.8% Mar 31, 2015
Q4 2014 35 -16.2 -31.7% Dec 31, 2014
Q3 2014 36 -25.8 -41.8% Sep 30, 2014
Q2 2014 35.7 -115 -76.3% Jun 30, 2014
Q1 2014 42.7 Mar 31, 2014
Q4 2013 51.2 Dec 31, 2013
Q3 2013 61.9 Sep 30, 2013
Q2 2013 151 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.